Shock waves aren’t just for OverwatchFDA (An agency within the U.S. Department of Health and Human Services) has approved a Sanuwave for its dermaPACE (Pulsed Acoustic Cellular Expression) System, which treats chronic and acute conditions of the skin and subcutaneous tissue.

ALSO READ: FCC Approves Energous WattUp Power-At-A-Distance Charging System!

First Shock Wave Device; dermaPACE!

The approval of dermaPACE System is specifically to help heal foot ulcers in diabetic patients, where the damaged blood vessels and nerves can lead to reduced circulation, infection or sometimes amputation.



So, what dermaPACE does is that it stimulates the wound and promotes healing. Much like any other FDA approved devices, the device also went through the de novo premarket review pathway, designed specifically to get the technology out on the market.

According to the double-blind studies, the results of showed an increase in wound healing at 24 weeks with a 44 percent wound closure rate with the real dermaPACE device versus 30 percent closure rate for patients with a fake system. FDA has approved the device and it opens the door for similar technology.


For the latest tech news, follow TechDipper on Twitter, Facebook, Google+, Instagram and subscribe to our YouTube channel.